Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion

Purpose: To compare functional and anatomic outcomes of treatment with intravitreal aflibercept versus bevacizumab and/or ranibizumab in patients with recurrent macular edema (ME) secondary to central retinal vein occlusion (CRVO). Methods: Retrospective, comparative case series of patients with rec...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Ocul Pharmacol Ther
Egile Nagusiak: Ozgonul, Cem, Dedania, Vaidehi S., Besirli, Cagri G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc. 2018
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5952344/
https://ncbi.nlm.nih.gov/pubmed/29447089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2017.0074
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak